Tag: AEZS

  • Aeterna Zentaris Inc. (AEZS) Releases 2020 Financial Earnings

    Aeterna Zentaris Inc. (AEZS) is a biopharmaceutical company that specializes in manufacturing and distributing therapeutics and tests used for medical diagnosis. The company is also expanding its current development pipeline and clinical trials of macimorelin- which will be used in the diagnosis of a growth hormone deficiency, an area without adequate medical need.

    The company Regained agreement with minimum bid price policy for continued listing on Nasdaq and AEZS common shares had a close bought deal for gross capital exceeding $34 million. The company also received $20M in capital from share dilution and using warrants.

    AEZS Plans For Pipeline Expansion

    AEZS continued to execute its pipeline expansion developing its pre-clinical programs via several licensing agreements with European universities. The Company started an official license agreement with Julius-Maximilians-University of Wuerzburg, Germany, having international patent and rights to produce and advertise, extremely distinct immunosuppressive protein therapeutics expecting treatment for Neuromyelitis Optica spectrum disorder, which has an unmet medical need.

    The company also amended its current license with Novo Nordisk for manufacturing Macrilen to penetrate Canadian and American markets.  AEZS is currently meeting the concerned medical authorities for confirmation of preclinical data required to advance into human clinical trials.

    Production of a Potential Oral Bacterial Vaccine For COVID-19

    AEZS has announced to be part of an exclusive international sub-licensable contract for a COVID 19 vaccine which is present in an initial development phase at the Julius-Maximilians-University. The company has a research agreement and is already looking for a pre-clinical trial for the potential vaccine.

    The vaccine uses the salmonella strain as an orally active live-attenuated bacteria to prevent COVID 19 improving the immune response against mutated viruses.

    Conclusion

    AEZS is in the lucrative field of biopharmaceuticals and is keen on research for vaccines of COVID and diseases with unmet medical needs. Savvy financial moves like share dilution and close bought deals have given the company a market capitalization of a staggering $135M and is anticipating a surge in revenue if the covid 19 vaccines produce efficient results.

  • Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after ‎reporting the appointment of a vaccine scientific advisory board comprised of leading academic and ‎industry experts in the vaccine field.‎

    Sundial Growers Inc. (SNDL), a Drug Manufacturers – Specialty & Generic ‎company, ‎dropped about -3.24% at $0.4838 in pre-market trading Thursday.‎

    Jaguar Health Inc. (NASDAQ: JAGX) shares are trading down -22.43% at $0.83 at the ‎time of writing after signing second agreement for $6 million non-dilutive financing transaction ‎involving the sale of royalty rights related to future Mytesi (Crofelemer) and Lechlemer revenue ‎Sstream. Company’s 52-week ranged between $0.19 to $1.08. Analysts have a consensus price target ‎of $2. ‎

    Onconova Therapeutics Inc. (ONTX) stock moved down -7.92 percent to ‎‎$0.465 ‎in ‎the pre-market trading.‎

    Acasti Pharma Inc. (ACST) tumbled over -4.77% at $0.4095 in pre-market trading ‎today following the announcement from the company that the Company’s management and Board of ‎Directors are unaware of any material change in the Company’s operations that would account for the ‎recent increase in market activity.‎

    FuelCell Energy Inc. (FCEL) lost over -4.55% at $12.81 in pre-‎market ‎trading ‎Thursday ‎December 24, 2020.‎

    Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading down -3.87% at $0.745 ‎at the time of writing after the company announced publication revealing in side-by-side comparison ‎that method using PacBio sequencing ‎detects only 72% of the large structural variants detected by ‎optical Genome Mapping with Saphyr.‎ Company’s 52-week ranged between $0.25 to $1.39. Analysts ‎have a consensus price target of $1.25. ‎

    Marathon Patent Group Inc. (NASDAQ: MARA) shares are trading ‎up ‎‎7.31% ‎at ‎‎$11.6 ‎at the time of writing. Company’s 52-week ranged between $0.35 to ‎‎$14.08. ‎Analysts ‎have ‎a ‎consensus price target of $7.50.‎

    Zomedica Corp. (ZOM) is down more than -2.48% at $0.22 in pre-‎‎‎market ‎hours ‎Thursday December 24, 2020. The stock had jumped over 17.50% to $0.23 in ‎the ‎last ‎trading ‎session.‎

    Nano Dimension Ltd. (NNDM) is up more than 7.18% at $9.4 in pre-‎‎market ‎hours ‎Thursday December 24, 2020. The stock had dropped over -3.41% to $8.77 in the ‎last ‎trading ‎session.‎

    Before the trading started on December 24, 2020, Senseonics Holdings Inc. (SENS) is ‎up 79.29% to reach $1.16 following its declaration of financial and operational business updates. It has ‎been trading in a 52-week range of $0.35 to $1.78.‎

    Corbus Pharmaceuticals Holdings Inc. (CRBP) lost over -2.08% at $1.41 in pre-‎‎market ‎trading Thursday December 24, 2020.‎

    Before the trading started on December 24, 2020, Foresight Autonomous ‎Holdings ‎Ltd. ‎‎(FRSX) is down -20.87% to reach $4.55. It has been trading in a 52-week range ‎of $0.46 ‎to ‎‎$3.40.‎

    Canaan Inc. (CAN) is up more than 2.12% at $3.85 in pre-‎market ‎hours ‎Thursday ‎December 24, 2020. The stock had dropped over -8.94% to $3.77 in the last ‎trading ‎session.‎

    Avinger Inc. (AVGR) stock soared 76.25% to $0.61 in the pre-market trading after ‎reporting results of its annual meeting of stockholders. The most recent rating by Ladenburg ‎Thalmann, on March 09, 2018, is a Buy.‎

    Triterras Inc. (NASDAQ: TRIT) shares are trading up 16.58% at $14.06 ‎at ‎the ‎time ‎of ‎writing. Company’s 52-week ranged between $7.70 to $15.17. Analysts have ‎a ‎consensus ‎price ‎target ‎of $23.‎

    Tantech Holdings Ltd (TANH), a Household & Personal Products ‎company, ‎rose ‎about 3.29% at $1.57 in pre-market trading Thursday.‎

    Tonix Pharmaceuticals Holding Corp. (TNXP) grew over 36.36% at $0.9 in pre-market ‎trading today following the announcement from the firm that it has completed the purchase of an ‎approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine development and ‎commercial scale manufacturing facility. ‎

    Gold Resource Corporation (GORO) stock moved down -6.85 percent to ‎‎$3.4 ‎in ‎the ‎pre-market trading.‎

    Nikola Corporation (NKLA) gained over 1.8% at $15.3 in pre-market trading ‎Thursday December 24, 2020. The company reported, on Wednesday, that Nikola and Republic ‎Services (RSG) have discontinued their collaboration on refuse truck development.‎

    Molecular Data Inc. (MKD) gained over 2.94% at $0.9027 in pre-‎‎‎market ‎trading ‎Thursday December 24, 2020.‎

    Gevo Inc. (GEVO), a Specialty Chemicals company, rose about 1.03% at $2.94 in pre-‎‎‎‎‎‎market trading Thursday.‎

    IZEA Worldwide Inc. (NASDAQ: IZEA) shares are trading up 3.9% at $1.6 at the time ‎of writing after reporting that it has set a Managed Services bookings record for the best Q4 in ‎company history. Company’s 52-week ranged between $0.07 to $3.13. IZEA Managed Services ‎Bookings Top 40% Growth in Q4 to Hit Record.‎

    Novan Inc. (NOVN) grew over 6.81% at $0.737 in pre-market trading today.‎

    Before the trading started on December 24, 2020, ReWalk Robotics Ltd. (RWLK) is ‎up 9.2% to reach $1.9. The firm recently revealed that it has donated one of its ReStore Exo-suits to ‎Brooks Rehabilitation, located in Jacksonville, Florida. It has been trading in a 52-week range of $0.41 to ‎‎$2.71.‎

    Inuvo Inc. (AMEX: INUV) shares are trading up 2.16% at $0.52 at the ‎time ‎of ‎writing. ‎Company’s 52-week ranged between $0.09 to $1.11. Analysts have a consensus price ‎target ‎of ‎‎$2.25.‎

    Aurora Mobile Limited (JG) stock soared 8.16% to $4.11 in the pre-market trading ‎following the announcement of a partnership deal with Taikang Life Insurance Co., Ltd., to strengthen ‎smart insurance solutions with AI rechnologies. The most recent rating by Goldman, on March 06, ‎‎2019, is a Neutral.‎

    fuboTV Inc. (FUBO) stock soared 3.73% to $54.55 in the pre-market ‎trading. ‎The ‎most recent rating by BMO Capital Markets, on December 23, 2020, is a Market perform.‎

    Farmmi Inc. (FAMI) is down more than -2.61% at $1.12 in pre-market hours ‎Thursday December 24, 2020. The company recently revealed its sales win to multi-channel ‎customers with over 100 retail stores in China and Canada. The stock had jumped over 1.77% to $1.15 ‎in the last trading session.‎